Press releases

Study results of prucalopride in elderly patients with chronic constipation
Turnhout (Belgium) – 28 June 2010 (5:45 PM CET) – Movetis NV (MOVE), the European gastrointestinal (GI) speciality ... Read more >
28/06/2010
|
Corporate
|
All
application/pdf icon
Press release study results of prucalopride in elderly CC patients.pdf
Movetis starts Phase III clinical trial with prucalopride in patients with opioid-induced constipation (OIC)
New trial marks first step in Movetis’ label expansion strategy for Resolor® Dutch Version Read more >
19/05/2010
|
Investors
|
English
application/pdf icon
Movetis starts clinical trial with prucalopride in OIC
Movetis start Fase III klinische studie met prucalopride bij patiënten met door opioïden geïnduceerde constipatie (OIC)
19/05/2010
|
Investors
Read more >
Trading Update 1stQ/2010 - Movetis advances business plan while controlling expenditure
03/05/2010
|
Investors
Read more >
Algemene vergadering Movetis / General Meeting
03/05/2010
|
Investors
Read more >

Go to archive >

Print

 MailMail